Accesso libero

Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

E. Karamitrousis

E. Karamitrousis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Karamitrousis, E.
, 
I. Balgkouranidou

I. Balgkouranidou

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Balgkouranidou, I.
, 
N. Xenidis

N. Xenidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Xenidis, N.
, 
K. Amarantidis

K. Amarantidis

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Amarantidis, K.
, 
E. Biziota

E. Biziota

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Biziota, E.
, 
T. Koukaki

T. Koukaki

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Koukaki, T.
 e 
S. Kakolyris

S. Kakolyris

University Medical Oncology Department, Medical School, Democritus University of ThraceAlexandroupolis, Greece
Cerca questo autore su
Sciendo|Google Scholar
Kakolyris, S.
  
07 mag 2022
Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Research Article
Pubblicato online: 07 mag 2022
Pagine: 72 - 76
Ricevuto: 14 ott 2021
Accettato: 23 dic 2021
DOI: https://doi.org/10.2478/fco-2021-0010
Parole chiave
© 2021 Karamitrousis E. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Gastric cancer is one of the most common cancers worldwide. The amount of cell-free DNA (cfDNA) in the blood of patients with gastric cancer was found to be higher than that of healthy controls (69.1 ng/μL vs. 34.8 ng/μL). Patients with cfDNA ≤ 50 ng/μL were found to have an increased overall survival (OS) and progression free survival (PFS) than in patients with cfDNA > 50 ng/μL.

Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia
Feed RSS della rivista